Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Weiwen Liu; Huihong Xu; Xihui Ying; Dengke Zhang; Linqiang Lai; Linyou Wang; Jianfei Tu; Jiansong Ji

doi:10.12659/MSM.923263

15 July 2020 : Clinical Research

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Weiwen Liu^1ABC*, Huihong Xu^2DE, Xihui Ying^1EFG, Dengke Zhang^1CD, Linqiang Lai^1BC, Linyou Wang^3EF, Jianfei Tu^1CFG, Jiansong Ji^1BDG

DOI: 10.12659/MSM.923263

Med Sci Monit 2020; 26:e923263

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Table 1 The demographic information and clinical characteristics of the patients.

Characteristic	TACE+RFA	TACE	P	Characteristic	TACE+RFA	TACE	P
Age			0.972	Child-Pugh class			0.097
≤60	76	47		A	114	65
>60	48	30		B	10	12
Sex			0.649	BCLC stage			<0.001
Male	112	71		A	36	5
Female	12	6		6B	88	72
HBV infection			0.326	AFP level			0.113
Yes	107	70		≤200 U/L	80	41
No	17	7		>200 U/L	44	36
Cirrhosis			0.138	ALT			0.646
Yes	76	39		≤40	70	46
No	48	38		>40	54	31
History of surgery			0.253	AST level			0.089
6Yes	20	8		≤40	56	22
No	104	69		>40	68	55
Tumor size			<0.001	First TACE			0.474
≤5 cm	70	16		Initial	50	35
5–10 cm	54	61		Recurrent	74	42
No. nodules			0.027	Complete ablation			<0.001
One	73	33		Yes	92	17
More	51	44		No	32	60

Back to the Article

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Your Privacy